Literature DB >> 32352857

Genomics Paves the Way for Better Infant Medulloblastoma Therapy.

Giles W Robinson1, Amar Gajjar1.   

Abstract

Entities:  

Mesh：

Year:  2020        PMID： 32352857      PMCID： PMC7302953          DOI： 10.1200/JCO.20.00593

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN： 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  7 in total

1.  Phase II Study of Nonmetastatic Desmoplastic Medulloblastoma in Children Younger Than 4 Years of Age: A Report of the Children's Oncology Group (ACNS1221).

Authors:  Lucie Lafay-Cousin; Eric Bouffet; Douglas Strother; Vasilisa Rudneva; Cynthia Hawkins; Charles Eberhart; Craig Horbinski; Linda Heier; Mark Souweidane; Chris Williams-Hughes; Arzu Onar-Thomas; Catherine A Billups; Maryam Fouladi; Paul Northcott; Giles Robinson; Amar Gajjar
Journal:  J Clin Oncol       Date:  2019-11-27       Impact factor: 44.544

2.  Intertumoral Heterogeneity within Medulloblastoma Subgroups.

Authors:  Florence M G Cavalli; Marc Remke; Ladislav Rampasek; John Peacock; David J H Shih; Betty Luu; Livia Garzia; Jonathon Torchia; Carolina Nor; A Sorana Morrissy; Sameer Agnihotri; Yuan Yao Thompson; Claudia M Kuzan-Fischer; Hamza Farooq; Keren Isaev; Craig Daniels; Byung-Kyu Cho; Seung-Ki Kim; Kyu-Chang Wang; Ji Yeoun Lee; Wieslawa A Grajkowska; Marta Perek-Polnik; Alexandre Vasiljevic; Cecile Faure-Conter; Anne Jouvet; Caterina Giannini; Amulya A Nageswara Rao; Kay Ka Wai Li; Ho-Keung Ng; Charles G Eberhart; Ian F Pollack; Ronald L Hamilton; G Yancey Gillespie; James M Olson; Sarah Leary; William A Weiss; Boleslaw Lach; Lola B Chambless; Reid C Thompson; Michael K Cooper; Rajeev Vibhakar; Peter Hauser; Marie-Lise C van Veelen; Johan M Kros; Pim J French; Young Shin Ra; Toshihiro Kumabe; Enrique López-Aguilar; Karel Zitterbart; Jaroslav Sterba; Gaetano Finocchiaro; Maura Massimino; Erwin G Van Meir; Satoru Osuka; Tomoko Shofuda; Almos Klekner; Massimo Zollo; Jeffrey R Leonard; Joshua B Rubin; Nada Jabado; Steffen Albrecht; Jaume Mora; Timothy E Van Meter; Shin Jung; Andrew S Moore; Andrew R Hallahan; Jennifer A Chan; Daniela P C Tirapelli; Carlos G Carlotti; Maryam Fouladi; José Pimentel; Claudia C Faria; Ali G Saad; Luca Massimi; Linda M Liau; Helen Wheeler; Hideo Nakamura; Samer K Elbabaa; Mario Perezpeña-Diazconti; Fernando Chico Ponce de León; Shenandoah Robinson; Michal Zapotocky; Alvaro Lassaletta; Annie Huang; Cynthia E Hawkins; Uri Tabori; Eric Bouffet; Ute Bartels; Peter B Dirks; James T Rutka; Gary D Bader; Jüri Reimand; Anna Goldenberg; Vijay Ramaswamy; Michael D Taylor
Journal:  Cancer Cell       Date:  2017-06-12       Impact factor: 31.743

3.  Risk-adapted therapy for young children with medulloblastoma (SJYC07): therapeutic and molecular outcomes from a multicentre, phase 2 trial.

Authors:  Giles W Robinson; Vasilisa A Rudneva; Ivo Buchhalter; Catherine A Billups; Sebastian M Waszak; Kyle S Smith; Daniel C Bowers; Anne Bendel; Paul G Fisher; Sonia Partap; John R Crawford; Tim Hassall; Daniel J Indelicato; Frederick Boop; Paul Klimo; Noah D Sabin; Zoltan Patay; Thomas E Merchant; Clinton F Stewart; Brent A Orr; Jan O Korbel; David T W Jones; Tanvi Sharma; Peter Lichter; Marcel Kool; Andrey Korshunov; Stefan M Pfister; Richard J Gilbertson; Robert P Sanders; Arzu Onar-Thomas; David W Ellison; Amar Gajjar; Paul A Northcott
Journal:  Lancet Oncol       Date:  2018-05-16       Impact factor: 41.316

4.  Nonmetastatic Medulloblastoma of Early Childhood: Results From the Prospective Clinical Trial HIT-2000 and An Extended Validation Cohort.

Authors:  Martin Mynarek; Katja von Hoff; Torsten Pietsch; Holger Ottensmeier; Monika Warmuth-Metz; Brigitte Bison; Stefan Pfister; Andrey Korshunov; Tanvi Sharma; Natalie Jaeger; Marina Ryzhova; Olga Zheludkova; Andrey Golanov; Elisabeth Jane Rushing; Martin Hasselblatt; Arend Koch; Ulrich Schüller; Andreas von Deimling; Felix Sahm; Martin Sill; Markus J Riemenschneider; Hildegard Dohmen; Camelia Maria Monoranu; Clemens Sommer; Ori Staszewski; Christian Mawrin; Jens Schittenhelm; Wolfgang Brück; Katharina Filipski; Christian Hartmann; Matthias Meinhardt; Klaus Pietschmann; Christine Haberler; Irene Slavc; Nicolas U Gerber; Michael Grotzer; Martin Benesch; Paul Gerhardt Schlegel; Frank Deinlein; André O von Bueren; Carsten Friedrich; Björn-Ole Juhnke; Denise Obrecht; Gudrun Fleischhack; Robert Kwiecien; Andreas Faldum; Rolf Dieter Kortmann; Marcel Kool; Stefan Rutkowski
Journal:  J Clin Oncol       Date:  2020-04-24       Impact factor: 44.544

Review 5.  Risk stratification of childhood medulloblastoma in the molecular era: the current consensus.

Authors:  Vijay Ramaswamy; Marc Remke; Eric Bouffet; Simon Bailey; Steven C Clifford; Francois Doz; Marcel Kool; Christelle Dufour; Gilles Vassal; Till Milde; Olaf Witt; Katja von Hoff; Torsten Pietsch; Paul A Northcott; Amar Gajjar; Giles W Robinson; Laetitia Padovani; Nicolas André; Maura Massimino; Barry Pizer; Roger Packer; Stefan Rutkowski; Stefan M Pfister; Michael D Taylor; Scott L Pomeroy
Journal:  Acta Neuropathol       Date:  2016-04-04       Impact factor: 17.088

6.  Prognostic significance of molecular subgroups of medulloblastoma in young children receiving irradiation-sparing regimens.

Authors:  Kee Kiat Yeo; Ashley S Margol; Rebekah J Kennedy; Long Hung; Nathan J Robison; Girish Dhall; Shahab Asgharzadeh
Journal:  J Neurooncol       Date:  2019-10-16       Impact factor: 4.130

7.  Robust molecular subgrouping and copy-number profiling of medulloblastoma from small amounts of archival tumour material using high-density DNA methylation arrays.

Authors:  Volker Hovestadt; Marc Remke; Marcel Kool; Torsten Pietsch; Paul A Northcott; Roger Fischer; Florence M G Cavalli; Vijay Ramaswamy; Marc Zapatka; Guido Reifenberger; Stefan Rutkowski; Matthias Schick; Melanie Bewerunge-Hudler; Andrey Korshunov; Peter Lichter; Michael D Taylor; Stefan M Pfister; David T W Jones
Journal:  Acta Neuropathol       Date:  2013-05-14       Impact factor: 17.088
  7 in total
  7 in total

1.  Young children with medulloblastoma: important open questions and the high-risk dilemma.

Authors:  Martin Mynarek; Stefan Rutkowski
Journal:  Neuro Oncol       Date:  2020-12-18       Impact factor: 12.300

Review 2.  2021 WHO classification of tumours of the central nervous system: a review for the neuroradiologist.

Authors:  Cillian McNamara; Kshitij Mankad; Stefanie Thust; Luke Dixon; Clara Limback-Stanic; Felice D'Arco; Thomas S Jacques; Ulrike Löbel
Journal:  Neuroradiology       Date:  2022-07-22       Impact factor: 2.995

Review 3.  Medulloblastoma in the Modern Era: Review of Contemporary Trials, Molecular Advances, and Updates in Management.

Authors:  Margot A Lazow; Joshua D Palmer; Maryam Fouladi; Ralph Salloum
Journal:  Neurotherapeutics       Date:  2022-07-20       Impact factor: 6.088

Review 4.  Imaging diagnosis and treatment selection for brain tumors in the era of molecular therapeutics.

Authors:  Saivenkat Vagvala; Jeffrey P Guenette; Camilo Jaimes; Raymond Y Huang
Journal:  Cancer Imaging       Date:  2022-04-18       Impact factor: 5.605

Review 5.  The 2021 WHO Classification of Tumors of the Central Nervous System: a summary.

Authors:  David N Louis; Arie Perry; Pieter Wesseling; Daniel J Brat; Ian A Cree; Dominique Figarella-Branger; Cynthia Hawkins; H K Ng; Stefan M Pfister; Guido Reifenberger; Riccardo Soffietti; Andreas von Deimling; David W Ellison
Journal:  Neuro Oncol       Date:  2021-08-02       Impact factor: 13.029

Review 6.  Pediatric versus Adult Medulloblastoma: Towards a Definition That Goes beyond Age.

Authors:  Joseph R Wooley; Marta Penas-Prado
Journal:  Cancers (Basel)       Date:  2021-12-16       Impact factor: 6.639

Review 7.  Genetic syndromes predisposing to pediatric brain tumors.

Authors:  Sameer Farouk Sait; Michael F Walsh; Matthias A Karajannis
Journal:  Neurooncol Pract       Date:  2021-02-13
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.